CBD of Denver Outlines Growth Strategy for BioCannabis, Its Integrated European CBD and CBG Production Platform
Nea Apollonia, Greece--(Newsfile Corp. - October 29, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBD of Denver" or the "Company") today outlined the strategic priorities for BioCannabis, its operating business in Northern Greece, following the commercial relaunch of the business. Established Platform for Growth Through BioCannabis, CBD of Denver operates an integrated CBD and CBG production platform combining cultivation, processing and extraction within a single ope
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-10-29 8:30 AM EDT | CBD of Denver Inc.
BioHarvest Sciences to Report Third Quarter 2026 Financial Results on November 12, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will report its third quarter 2026 financial results before the market opening on Thursday, November 12, 2026. The Company will host a conference call and webcast at 8:00 AM Eastern Time to
Biotechnologies, Pharmaceutique, Santé
2026-10-29 8:00 AM EDT | BioHarvest Sciences Inc.
Delivra Health Brands Reports FY2026 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer-packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its financial and operating results for the 12 months ended June 30, 2026 ("fiscal 2026"). The Delivra Health portfolio features innovative brands Dream Water® and LivRelief™, which deliver
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-10-28 5:53 PM EDT | Delivra Health Brands Inc.
Charlotte's Web to Report Third Quarter 2026 Results on November 12
Louisville, Colorado--(Newsfile Corp. - October 28, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and market leader in cannabidiol (CBD) hemp extract wellness products, will report its 2026 third quarter financial results before market open on November 12, 2026, and will file its Quarterly Report on Form 10-Q the same da
2026-10-28 9:14 AM EDT | Charlotte's Web Holdings, Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Agreement to Supply PEX010 to Linkoping University for PsiloSAD Trial in Social Anxiety Disorder
Toronto, Ontario--(Newsfile Corp. - October 28, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Fil
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-10-28 8:00 AM EDT | Rhelion Life Sciences Corp.
Promino Adds Associated Wholesale Grocers to U.S. Retail Expansion
Burlington, Ontario--(Newsfile Corp. - October 28, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a muscle health and performance nutrition company, announces it has received an initial purchase order for Rejuvenate Muscle Health™ through Associated Wholesale Grocers, Inc. ("AWG"). The order supports planned retail placement at 20 Balls Food Stores locations in the Kansas City area. AWG is a retailer-owned wholesale gr
Aliments / boissons, Sports, Santé
2026-10-28 7:00 AM EDT | Promino Nutritional Sciences, Inc.
Rise Nano Optics Announces Establishment of New SpectraGuard(TM) Nanomaterial Production Facility in Israel
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced established a new nanomaterial production facility within Sagam Optical Products Ltd. ("Sagam") facilities in Israel dedicated to manufacturing the Company's proprietary nanomaterial used in
2026-10-28 7:00 AM EDT | Rise Nano Optics Ltd.
WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter
British Columbia and Toronto, Ontario--(Newsfile Corp. - October 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, and HEALWELL AI Inc. (TSX: AIDX) ("HEALWELL"), a healthcare artificial intelligence company focused on preventative care, today announce
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-10-28 6:00 AM EDT | WELL Health Technologies Corp.
TempraMed Signs Exclusive Distribution Agreement with SPORTORO for Croatia, Serbia and Bosnia and Herzegovina
Highlights Definitive exclusive distribution agreement with SPORTORO d.o.o. for Croatia, Serbia and Bosnia and Herzegovina. Commercial scope covers VIVI Cap™, VIVI Epi™ and VIVI Med™, extending access across insulin pens, epinephrine auto-injectors, vials and other compatible temperature-sensitive medication formats. The agreement contemplates the initial order is to be placed and fully paid in
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-10-28 3:05 AM EDT | TempraMed Technologies Ltd.
Edison Issues Report on Premia Properties (PREMIA)
London, United Kingdom--(Newsfile Corp. - October 27, 2026) - Edison issues report on Premia Properties (ATHEX: PREMIA). Premia Properties REIC offers investors sustainable long-term income from a diversified portfolio of properties that has grown rapidly over the past five years. During this time, Premia has demonstrated its ability to source high-yielding assets, sustaining a portfolio gross yield consistently above 7%, while maintaining virtually full occupancy. We expect recent inve
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-10-27 10:38 AM EDT | Edison Group
BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm
Vancouver, British Columbia--(Newsfile Corp. - October 27, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), a biotechnology company developing BETR-001 for chronic cluster headache and chronic migraine, today announced that it has retained LifeSci Advisors ("LifeSci" or "LifeSci Advisors") to support its investor relations and corporate communications activities. The engagement of LifeSci is being completed pursuant to t
2026-10-27 8:00 AM EDT | BetterLife Pharma Inc.
Ubiquitech Software Corp. (UBQU) Explores Strategic Merger Opportunities in the Growing Specialty Materials and Advanced Textile Manufacturing Industry
Tampa, Florida--(Newsfile Corp. - October 26, 2026) - Ubiquitech Software Corp. (OTCID: UBQU) ("UBQU" or the "Company") today announced that management is exploring potential merger opportunities within the specialty materials and advanced textile manufacturing industry as part of its broader corporate growth strategy. Management's review includes businesses operating in synthetic fiber manufacturing, specialty yarn production, and advanced textile materials-industries that serve a
2026-10-26 8:30 AM EDT | Ubiquitech Software Corp.
CBD of Denver, Inc. Announces Operating Business Relaunch Following BioCannabis Agreement and New International Supply Contracts
Nea Apollonia, Greece--(Newsfile Corp. - October 26, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced continued progress in the relaunch and expansion of the operating business of BioCannabis M. IKE ("BioCannabis"), a Greece-based vertically integrated hemp and cannabinoid company with established business-to-business ("B2B") wholesale operations and an expanding network of commercial customers. CBDD entered into a definitive Share Exchange Agre
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-10-26 8:30 AM EDT | CBD of Denver Inc.
Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues
Winter Park, Florida--(Newsfile Corp. - October 26, 2026) - Adia Med Inc. (OTCQB: ADIA) today reported interim safety observations from the first cohort of its randomized Phase 1/2 investigational study in children with autism spectrum disorder (ASD). Investigators reported no serious adverse events in either study arm and no events requiring reporting to the Institutional Review Board (IRB). Enrollment continues under the protocol's staggered schedule, and first-cohort participants remain in
Soins de santé et hôpitaux, Santé
2026-10-26 8:00 AM EDT | Adia Med Inc.
Rise Nano Optics to Present at Planet MicroCap Toronto 2026
Vancouver, British Columbia--(Newsfile Corp. - October 26, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, is pleased to announce that members of its management team will participate in Planet MicroCap Toronto 2026, taking place October 27–29, 2026, in Toronto, Ontario. Planet MicroCap Toronto brings together microcap compani
2026-10-26 7:00 AM EDT | Rise Nano Optics Ltd.
Therma Bright Announces up to $420,000 Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - October 23, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced medical device technologies, announces that it proposes to undertake a non-brokered private placement of up to 14,000,000 common shares (the "Shares") at a price of $0.03/Share for total proceeds of up to $420,000 (the "Offering"). In accordance with the policies
Technologies, Biotechnologies, Santé
2026-10-23 8:37 PM EDT | Therma Bright Inc.
Unbuzzd Wellness Announces Closing of Private Placement Financing
Vancouver, British Columbia--(Newsfile Corp. - October 23, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™, is pleased to announce that it has completed its non-brokered private placement financing (the "Offering") in two tranches for aggregate gross proceeds of $1,080,000 through the issuance of an aggregate of 5,400,000 common shares in the share capital of the Company (the "Shares") at a price of $0.20 per Share. The Company
2026-10-23 7:00 PM EDT | Unbuzzd Wellness Inc.
Defence Therapeutics Announces Convertible Debenture Interest Payment
Montreal, Quebec--(Newsfile Corp. - October 23, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® drug-delivery platform, is pleased to announce convertible debentures interest payment in common shares of the Company. The Company announces that, in accordance with the terms and condi
Biotechnologies, Pharmaceutique, Santé
2026-10-23 4:15 PM EDT | Defence Therapeutics Inc.
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - October 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased announce that, further to its news release dated September 28, 2026, it has closed an initial tranche (the "Initial Tranche") of its previously announced $600,000 non-brokered private placement (the "Offering"), which Initial Tranche consisted of the issuance of 5,200,000 units
Biotechnologies, Pharmaceutique, Santé
2026-10-22 5:24 PM EDT | PreveCeutical Medical Inc.
TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET
Clearwater, Florida--(Newsfile Corp. - October 22, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period end
Soins de santé et hôpitaux, Santé
2026-10-22 7:00 AM EDT | TelyRx